| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |